Drug interactions
Valganciclovir + Vinblastine
Severity: Moderate
Valganciclovir and Vinblastine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both drugs can suppress bone marrow, so combined use may deepen leukopenia, neutropenia and thrombocytopenia. The risk is additive and is most relevant in patients already receiving myelosuppressive chemotherapy.
What this interaction means in plain words
Valganciclovir and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Valganciclovir belongs to Anti Virals; Vinblastine belongs to Oncology.
Why it happens
Additive myelosuppressive effects (pharmacodynamic synergism).
What to do
Monitor complete blood counts frequently and reduce doses or delay treatment if severe cytopenias develop; consider growth factor support as indicated.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Valganciclovir and Vinblastine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Valganciclovir
Other interactions of Vinblastine
Frequently asked questions
Can I take Valganciclovir with Vinblastine?
MediHelp rates the interaction as moderate. Valganciclovir and Vinblastine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can suppress bone marrow, so combined use may deepen leukopenia, neutropenia and thrombocytopenia. The risk is additive and is most relevant in patients already receiving myelosuppressive chemotherapy.
How serious is the interaction between Valganciclovir and Vinblastine?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts frequently and reduce doses or delay treatment if severe cytopenias develop; consider growth factor support as indicated.
What other medicines interact with Valganciclovir?
MediHelp also lists interactions of Valganciclovir with, for example, Didanosine, Ganciclovir, Liposomal doxorubicin. The full list is on the Valganciclovir page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
